Literature DB >> 18156035

Genital herpes.

Rachna Gupta1, Terri Warren, Anna Wald.   

Abstract

Genital herpes is the main cause of genital ulcers worldwide; the prevalence of herpes simplex virus (HSV) type 2 infections in the general population ranges from 10% to 60%. Most genital herpes is caused by HSV-2, although HSV-1 accounts for about half of new cases in developed countries. The risk of HIV acquisition is three times higher in people with HSV-2. Neonatal herpes is an uncommon but serious complication of genital herpes. Most genital HSV-2 infections are unrecognised and undiagnosed; infected individuals, even with mild symptoms, shed HSV, and can infect sexual partners. Since clinical diagnosis is neither sensitive nor specific, virological and type-specific serological tests should be used routinely. Oral antiviral drugs for HSV infections are safe and effective and can be used both to treat episodes and to prevent recurrences. Antiviral treatment of the infected partners and condom use reduce the risk of sexual transmission of HSV-2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156035     DOI: 10.1016/S0140-6736(07)61908-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  198 in total

1.  Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIV.

Authors:  Darrell H S Tan; Janet M Raboud; Leah Szadkowski; Tae Joon Yi; Brett Shannon; Rupert Kaul; W Conrad Liles; Sharon L Walmsley
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-17       Impact factor: 2.205

2.  Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host cell adhesion.

Authors:  Na Zhang; Jinghua Yan; Guangwen Lu; Zhengfei Guo; Zheng Fan; Jiawei Wang; Yi Shi; Jianxun Qi; George F Gao
Journal:  Nat Commun       Date:  2011-12-06       Impact factor: 14.919

3.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

4.  Herpes simplex virus colitis complicating the course of a patient with Crohn's disease and cirrhosis: an underestimated association?

Authors:  Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

5.  Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.

Authors:  Martin P Däumer; Beate Schneider; Doris M Giesen; Sheriff Aziz; Rolf Kaiser; Bernd Kupfer; Karl E Schneweis; Jens Schneider-Mergener; Ulrich Reineke; Bertfried Matz; Anna M Eis-Hübinger
Journal:  Med Microbiol Immunol       Date:  2010-10-08       Impact factor: 3.402

6.  An innate antiviral pathway acting before interferons at epithelial surfaces.

Authors:  Marie B Iversen; Line S Reinert; Martin K Thomsen; Ieva Bagdonaite; Ramya Nandakumar; Natalia Cheshenko; Thaneas Prabakaran; Sergey Y Vakhrushev; Malgosha Krzyzowska; Sine K Kratholm; Fernando Ruiz-Perez; Steen V Petersen; Stanislas Goriely; Bo Martin Bibby; Kristina Eriksson; Jürgen Ruland; Allan R Thomsen; Betsy C Herold; Hans H Wandall; Sebastian Frische; Christian K Holm; Søren R Paludan
Journal:  Nat Immunol       Date:  2015-11-30       Impact factor: 25.606

7.  Evaluation of Herpes Simplex Virus Type 2 Serological Tests for Use With Dried Blood Spots in Kenya.

Authors:  Marcia M Hobbs; Sophie W Mwanyumba; Winnie K Luseno; Shane Hartman; Carolyn T Halpern; Denise D Hallfors; Hyunsan Cho
Journal:  Sex Transm Dis       Date:  2017-02       Impact factor: 2.830

8.  Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.

Authors:  Sita Awasthi; John W Balliet; Jessica A Flynn; John M Lubinski; Carolyn E Shaw; Daniel J DiStefano; Michael Cai; Martha Brown; Judith F Smith; Rose Kowalski; Ryan Swoyer; Jennifer Galli; Victoria Copeland; Sandra Rios; Robert C Davidson; Maya Salnikova; Susan Kingsley; Janine Bryan; Danilo R Casimiro; Harvey M Friedman
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

9.  SEROPREVALENCE AND RISK FACTORS OF HERPES SIMPLEX VIRUS TYPE 2 AMONGST PATIENTS' ATTENDING RETROVIRAL CLINIC IN FEDERAL MEDICAL CENTER ABEOKUTA, SOUTH-WEST NIGERIA.

Authors:  V U Nwadike; P Osinupebi; O Y Ojo; G B Imhonopi; O A Oyesola; C J Elikwu; W O Oladosu
Journal:  Ann Ib Postgrad Med       Date:  2020-06

10.  Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2.

Authors:  M J Binnicker; D J Jespersen; J A Harring
Journal:  Clin Vaccine Immunol       Date:  2009-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.